Search and volunteer to participate in these available studies at UB. Your participation in research doesn't just benefit you, it helps advance healthcare for our entire community.

Highlighted Searches
Search Clinical Trials
Filter on any fields below
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Showing 61 - 70 of 276 Clinical Trials
Description:
We are doing this study to find out if there is a connection between poor sleep in children with cystic fibrosis and the development of diabetes. Cystic Fibrosis patient and the parent will complete a single 10 minute survey about how CF patient sleeps. The study team will collect some information about the child’s health including the results of an oral glucose tolerance test. Read More
Eligibility:
Inclusion criteria include having cystic fibrosis, being 10 years old or older and either having an oral glucose tolerance test (a screen for CF-related diabetes) in 2020 or planning to have one in 2021. Exclusion criteria include a history of long-standing CF-related diabetes, liver failure or liver transplant or receipt of steroids within 6 weeks prior to the oral glucose tolerance test.
Contact(s)
AMANDA HASSINGER
albrooks@buffalo.edu
+1 716-878-7442
Description:
This study is for COPD patients 40 years and older who have been hospitalized and discharged within 90 days. These patients will be interviewed and take a one-time survey which takes 30-45 minutes. Read More
Eligibility:
Patient Criteria: 1) Age ≥40 years
2) GOLD stage ≥2, FEV1 <80% predicted
3) Hospitalized for an acute exacerbation for COPD
4) Discharged from the hospital setting within 90 days of the AECOPD
Caregivers: We will ask COPD patients to identify caregivers who might also be willing to participate in the caregiver interviews. A caregiver will be defined as a family me...
Contact(s)
DAVID JACOBS
dmjacobs@buffalo.edu
+1 716-829-2134
Description:
This study enrolls men with prostate cancer. The purpose of this study is to compare using radium-223 and docetaxel chemotherapy treatment vs. using docetaxel alone in men with Metastatic Castration-Resistant Prostate Cancer (mCRPC). Radium223 has been FDA approved to treat men with prostate cancer that has spread to the bone, but it has not been approved for men with cancer that has spread to soft tissue or in combination with the chemotherapy drug docetaxel. Read More
Eligibility:
Adults ages 18+.
Males with progressive Metastatic Prostate Cancer.
Have 2+ bone lesions.
Contact(s)
Jessica McCarthy
jm279@buffalo.edu
Description:
This study enrolls adults diagnosed with head and neck cancer who have plans to complete chemoradiotherapy. The purpose of this study is to learn the best timing for feeding tube placement and speech therapy to create the best quality of life for patients. Read More
Eligibility:
Adults ages 18+.
Patients with Head and Neck Cancer being treated at ECMC and Cancer Care WNY.
Patients planning to receive concurrent chemo-radiation therapy.
Contact(s)
Daniel Leon
dleon2@buffalo.edu
+1 716-859-4879
Description:
This study enrolls adults who have had a brain hemorrhage within the last 7 days. The purpose of the study is to learn whether it is better to keep taking or stop taking the medication statin after having a brain bleed. Read More
Eligibility:
Adults ages 50+.
Have had bleeding in the brain (brain hemorrhage) within the last 7 days.
Were taking a statin drug.
People who may be eligible for this study will be contacted by study staff directly. Eligible participants will be inpatients of Buffalo General/Gates Vascular Institute.
Description:
This study enrolls adults with schizophrenia who are currently in a treatment program for schizophrenia and your clinician is prescribing a Long Read More
Eligibility:
Adults ages 18+.
Diagnosis of schizophrenia.
Have just started treatment with one of four atypical Long Acting Injectable (LAI) medications (ABILIFY MAINTENA, ARISTADA, INVEGA SUSTENNA or RISPERDAL CONSTA)
Contact(s)
SEVIE KANDEFER
sk293@buffalo.edu
+1 716-898-4038
Description:
This study enrolls adults with a blockage in an artery in their heart that needs to be tested to determine if it should be treated. The purpose of this study is to collect data and measurements to find out if you need you need an interventional procedure to open your blood vessel or artery. Read More
Eligibility:
Adults ages 18+.
Have at least 1 non-stented lesion in 1 or more major epicardial vessels of 40-90% angiographic stenosis.
Contact(s)
ROBIN STEIN
rmstein3@buffalo.edu
+1 716-888-4859
Description:
This study enrolls adults with Congenital Adrenal Hyperplasia. The purpose of this study is to see if an investigational drug called tildacerfont is safe and effective in reducing the level of certain hormones in your body. Read More
Eligibility:
Adults ages 18-55.
Has a documented historical diagnosis of classic Congenital Adrenal Hyperplasia (CAH)
Contact(s)
Arsalan Mustafa
arsalanm@buffalo.edu
+1 716-548-9493
Description:
This study enrolls people who have been diagnosed with a blood clot blocking an artery in their brain (stroke). The blocked artery is opened by removing the blood clot using a small catheter (thin tube) device that is inserted into an artery through your arm or leg that leads to your brain. The purpose of this study is to find out if this specific new investigational catheter (ZOOM) leads to improved outcomes at 90 days. Read More
Eligibility:
Adults ages 18+
Diagnosed with a stroke
Nonpregnant females
Contact(s)
JENNIFER GAY
jgay@ubns.com
+1 716-888-4811
Description:
This study enrolls adults with nonalcoholic steatohepatitis (NASH). The purpose of this study is to learn about how much a medication called tirzepatide can help people with this condition. Read More
Eligibility:
Adults ages 18-80.
Overweight or obese.
Diagnosis of NASH by liver biopsy in the past 6 months.
Have fibrosis stage 2 or 3.
Contact(s)
Chelsea Cowan
cacowan@buffalo.edu
Showing 61 - 70 of 276 Clinical Trials
Not finding what you are looking for? Add your profile to the Buffalo Research Registry or ResearchMatch to be matched with future studies.